EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/03/2025
Voltar para busca
Dado oficial do USPTO
WID
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
05/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
01/12/2021
Data de registro
20/02/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/02/2024
Última transação
05/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Zams, AT
Examinador
NELMAN, JESSE
Unidade examinadora
O20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Sola Diagnostics GmbH
Representantes
John Mueller BAKER & HOSTETLER LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic biomarker reagents for medical purposes used in connection with a cervical swab to identify gynaecologic cancers of the cervixuterine bodyovary and breast; diagnostic kits comprised of medical assays for testing bodily fluidsbodily tissue and blood for use in disease detectiongynecological cancer andin particularcervicaluterineovarian and breast cancers; diagnostic reagents in kit form consisting of kits comprised primarily of diagnostic reagents for conducting assays for medical purposes; medical in vitro diagnostic reagents for polymerase chain reaction (pcr) technologies; medical diagnostic reagents; epigenetic test kits comprising reagents for testing and analysing bodily fluidsbodily tissue and blood for the diagnosis and detection of cancer; diagnostic reagents and kits of comprised primarily of diagnostic reagents for preparing moleculesdevicesconsumablesinstruments for the generation of sequencing datagenomic datacytogenetic datacytogenomic dataepigenetic datagenome physical structure datagenome temporal relationship datagenome spatial relationship datasubnucleus structure datacytosol structure datacellular organelle datacell structure datacell morphology data for medical diagnostic use
Classe 10
Medical apparatus for diagnostic testing of biological samplesbodily fluidsbody tissues and blood for the detection of cancer and disease; medical diagnostic apparatus for use in analytical tests for detecting cancer and disease from sample bodily fluidsbodily tissue and blood; instruments for making cervical smears; DNA and epigenetics testing apparatus for medical use; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of diseasedetection and identification of pathogensfor the detection of acquired and inherited genetic mutationsdetection and analysis of epigenetic alterations in relation to gynecological cancers of the cervixuterine bodyovary and breast
Classe 42
Scientific research for chemicalbiochemicalbiological or bacteriological purposes; scientific research for medical purposes; scientific and medical research services; electronic data storage services; scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; scientific and medical research and development services in the field of the diagnosis of diseasedetection and identification of pathogensfor the detection of acquired or inherited genetic mutationsfor detection and analysis of epigenetic alterations; research and development in the field of biological preparations and substances for the treatmentdiagnosisdetection and prevention of cancer
Classe 44
Medical diagnostic services; medical testing services relating to the diagnosis and treatment of diseases; medical diagnostic testing relating to the human body; blood testing services; biologicalchemicalbiochemicalbacteriologicalDNARNAproteinpolynucleic acid and molecular testing and analysis services and DNA/RNA sequencing services for medical purposes; consultancyadvisory and information services relating to medical research and development in the field of cancer diagnosis and detection
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/03/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
20/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/12/2023
PUBO
PUBLISHED FOR OPPOSITION
05/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/10/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/10/2023
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
18/10/2023
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
18/10/2023
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
18/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/10/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
17/10/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
19/07/2023
GNFR
FINAL REFUSAL E-MAILED
19/07/2023
CNFR
FINAL REFUSAL WRITTEN
19/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/07/2023
ALIE
ASSIGNED TO LIE
17/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/09/2022
GNRT
NON-FINAL ACTION E-MAILED
14/09/2022
CNRT
NON-FINAL ACTION WRITTEN
14/09/2022
DOCK
ASSIGNED TO EXAMINER
12/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2021
NWAP
NEW APPLICATION ENTERED
04/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WID ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.